World's Best Scientists 2026 revealed!
Christopher E. Brightling

Christopher E. Brightling

D-Index & Metrics

Immunology

D-Index
133
Citations
76193
World Ranking
208
National Ranking
21

Medicine

D-Index
133
Citations
83952
World Ranking
2188
National Ranking
231

Christopher E. Brightling publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Christopher E. Brightling sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 688 publications — 96th percentile

96% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Christopher E. Brightling D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Christopher E. Brightling sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 133 D-Index — 96th percentile

96% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • Fellow of The Academy of Medical Sciences, United Kingdom
  • Fellow of The Academy of Medical Sciences, United Kingdom
  • Fellow of The Academy of Medical Sciences, United Kingdom
  • Fellow of The Academy of Medical Sciences, United Kingdom

Overview

Christopher E. Brightling is affiliated with the University of Leicester in the United Kingdom. Their research primarily focuses on Medicine, with significant contributions to Pulmonary and Respiratory Medicine, Physiology, Neurology, Immunology, and Infectious Diseases.

The scientist has published extensively across frequent venues including:

  • European Respiratory Journal
  • American Journal of Respiratory and Critical Care Medicine
  • ERJ Open Research
  • bioRxiv (Cold Spring Harbor Laboratory)
  • The Lancet Respiratory Medicine

Key topics in their work cover a range of respiratory and immunological areas such as:

  • Asthma and respiratory diseases
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Long-Term Effects of COVID-19
  • Respiratory and Cough-Related Research
  • IL-33, ST2, and ILC Pathways
  • COVID-19 Clinical Research Studies
  • Respiratory Support and Mechanisms

Notable recent papers include:

  • "Dexamethasone in Hospitalized Patients with Covid-19," 2020, published in DiRROS repository (University of Maribor)
  • "Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma," 2021, New England Journal of Medicine
  • "Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study," 2021, The Lancet Respiratory Medicine
  • "Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge," 2021, EClinicalMedicine
  • "Global Initiative for Asthma Strategy 2021: executive summary and rationale for key changes," 2021, European Respiratory Journal

Frequent co-authors include:

  • Neil Greening
  • Rachael A Evans
  • Louise V. Wain
  • Amisha Singapuri
  • Betty Raman

The scientist has been recognized as a Fellow of The Academy of Medical Sciences, United Kingdom.

Best Publications

  • Allergic Rhinitis and its Impact on Asthma (ARIA): Achievements in 10 years and future needs

    J. Bousquet;H. J. Schünemann;B. Samolinski;P. Demoly

  • Dexamethasone in Hospitalized Patients with Covid-19

    P Horby;W S Lim;Emberson

  • International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma

    Kian Fan Chung;Sally E. Wenzel;Jan L. Brozek;Andrew Bush

  • Cluster analysis and clinical asthma phenotypes.

    Pranab Haldar;Ian D. Pavord;Dominic E. Shaw;Michael A. Berry

  • Mepolizumab and Exacerbations of Refractory Eosinophilic Asthma

    Pranabashis Haldar;Christopher E. Brightling;Beverley Hargadon;Sumit Gupta

  • Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial.

    Ruth H Green;Christopher E Brightling;Susan McKenna;Beverley Hargadon

  • Mast-Cell Infiltration of Airway Smooth Muscle in Asthma

    Christopher E. Brightling;Peter Bradding;Fiona A. Symon;Stephen T. Holgate

  • Acute Exacerbations of Chronic Obstructive Pulmonary Disease: Identification of Biologic Clusters and Their Biomarkers

    Mona Bafadhel;Susan McKenna;Sarah Terry;Vijay Mistry

  • Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids

    R H Green;C E Brightling;G Woltmann;D Parker

  • Evidence of a role of tumor necrosis factor alpha in refractory asthma.

    Mike A. Berry;Beverley Hargadon;Maria Shelley;Debbie Parker

  • Diagnosis and Management of Cough Executive Summary: ACCP Evidence-Based Clinical Practice Guidelines

    Richard S. Irwin;Michael H. Baumann;Donald C. Bolser;Louis Philippe Boulet

  • Uniform definition of asthma severity, control, and exacerbations: Document presented for the World Health Organization Consultation on Severe Asthma

    Jean Bousquet;Jean Bousquet;Eva Mantzouranis;Alvaro A. Cruz;Nadia Aït-Khaled

  • Global Initiative for Asthma (GINA) Strategy 2021 – Executive summary and rationale for key changes

    Helen K. Reddel;Helen K. Reddel;Leonard B. Bacharier;Leonard B. Bacharier;Eric D. Bateman;Eric D. Bateman;Christopher E. Brightling;Christopher E. Brightling

  • Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma.

    Andrew Menzies-Gow;Jonathan Corren;Arnaud Bourdin;Geoffrey Chupp

  • Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial

    Christopher E. Brightling;William Monteiro;Richard Ward;Debbie Parker

  • Blood Eosinophils to Direct Corticosteroid Treatment of Exacerbations of Chronic Obstructive Pulmonary Disease: A Randomized Placebo-Controlled Trial

    Mona Bafadhel;Susan McKenna;Sarah Terry;Vijay Mistry

  • Effect of Dexamethasone in Hospitalized Patients with COVID-19 – Preliminary Report

    P Horby;W S Lim;J Emberson;M Mafham

  • Eosinophilic Bronchitis Is an Important Cause of Chronic Cough

    Christopher E. Brightling;Richard Ward;Kah Lay Goh;Andrew J. Wardlaw

  • Severe eosinophilic asthma treated with mepolizumab stratified by baseline eosinophil thresholds: a secondary analysis of the DREAM and MENSA studies.

    Hector G Ortega;Steven W Yancey;Bhabita Mayer;Necdet B Gunsoy

  • Pathological features and inhaled corticosteroid response of eosinophilic and non-eosinophilic asthma

    Mike Berry;Angela Morgan;Dominick E Shaw;Deborah Parker

  • Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study.

    Rachael A Evans;Hamish McAuley;Ewen M Harrison;Aarti Shikotra

Frequent Co-Authors

Ian D. Pavord
Ian D. Pavord University of Oxford
Andrew J. Wardlaw
Andrew J. Wardlaw University of Leicester
Peter Bradding
Peter Bradding University of Leicester
Michael R. Barer
Michael R. Barer University of Leicester
Liam G. Heaney
Liam G. Heaney Queen's University Belfast
Dave Singh
Dave Singh University of Manchester
Robert Niven
Robert Niven University of Manchester
Kian Fan Chung
Kian Fan Chung Imperial College London
Neil C. Thomson
Neil C. Thomson University of Glasgow
Martin D. Tobin
Martin D. Tobin University of Leicester

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Immunology often leads students to related fields in healthcare, particularly nursing, where interdisciplinary knowledge is highly valued. For those interested in accelerating their nursing careers, accelerated RN to NP programs offer a fast-track route to becoming a nurse practitioner, combining advanced clinical skills with a solid foundation in immunological concepts.

If you're starting without a nursing background, consider online RN programs for non nurses in Florida, designed to accommodate learners transitioning into nursing from other fields. These programs emphasize flexibility and comprehensive training suited to immunology-related healthcare roles.

For individuals seeking a quicker entry into nursing, finding the easiest ABSN to get into can be a practical choice. These accelerated bachelor degree programs focus on essential nursing education, preparing students to contribute to immunological research and patient care swiftly.

Additionally, easy LPN programs to get into provide foundational nursing credentials with shorter timelines, catering to those who want to quickly enter the healthcare workforce and build experience that may later complement advanced studies in immunology.

Best Scientists Citing Christopher E. Brightling

Trending Scientists

Recently Published Articles